Share information
247.10 €
+1.65 %
23/04/2026 13:03
+1.65 %
Open
High
Low
Volume
241.50 €
247.80 €
240.10 €
38,051
Latest News
17-Apr-2026
UCB to acquire Neurona Therapeutics, advancing its innovative leadership in epilepsy through regenerative science
17-Apr-2026
Acquisition of own shares
15-Apr-2026
UCB presents new data demonstrating quality-of-life impacts for epilepsy patients and caregivers at AAN 2026 meeting
10-Apr-2026
Acquisition of own shares